Eurofins Discovery announced its premier offering for integrated drug discovery services. Eurofins Discovery has successfully collaborated with clients in integrated drug discovery programs and has a strong record of accomplishment of preclinical candidate delivery. The integrated services are marketed under the brand name of DiscoveryOne™.
DiscoveryOne™ defines the value of bringing together Eurofins Discovery’s full suite of services under one managed program backed by the expertise, services and program management required to support its client’s drug discovery projects.
The DiscoveryOne™ integrated drug discovery service is a hand-in-hand partner for the on-time delivery of a preclinical candidate at all phases. This is accomplished through integrated project management, deep scientific expertise and the broad in-house capabilities of Eurofins Discovery. Clients can take advantage of DiscoveryOne™ integrated services in multiple ways:
- Full-service integrated drug discovery, where experienced multidisciplinary Eurofins Discovery drug hunters (Biology, ADME, medicinal & synthetic chemistry teams) work collaboratively from hit ID to preclinical candidate.
- Modular integrated projects, where the Eurofins Discovery team partners with the client on one or more phases of drug discovery while coordinating with a client’s other service partners.
“DiscoveryOne™ expands the value that we can offer our clients,” stated Christina Shasserre, Sr. VP of Eurofins Discovery. “We have been offering services for all phases of drug discovery and can now assemble this offering into an integrated service with program management staffed from experts in drug discovery. This will provide our clients with the critical expertise to support their delivery of a preclinical candidate.”